Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 16,038 | 16,079 | 17,631 | 16,413 | 13,139 |
| Cost of Goods | 6,218 | 5,440 | 5,755 | 4,939 | 4,790 |
| Gross Profit | 9,820 | 10,639 | 11,876 | 11,474 | 8,349 |
| Operating Expenses | 17,777 | 15,699 | 19,442 | 48,886 | 31,456 |
| Operating Income | -7,739 | -4,620 | -6,811 | -36,473 | -22,317 |
| Interest Expense | 3,368 | 2,041 | 2,742 | 2,518 | 2,805 |
| Other Income | 153,401 | 618 | 18,406 | 27,337 | 431 |
| Pre-tax Income | 142,294 | -6,043 | 8,853 | -11,654 | -24,691 |
| Income Tax | 5,132 | -646 | 26 | N/A | 0 |
| Net Income Continuous | 137,162 | -5,397 | 8,827 | -11,654 | -24,691 |
| Minority Interests | 26,789 | -1,460 | 2,977 | -27,140 | -14,107 |
| Net Income | $110,373 | $-3,937 | $5,850 | $15,486 | $-10,584 |
| EPS Basic Total Ops | 3.44 | -0.22 | 0.13 | 0.50 | -0.48 |
| EPS Basic Continuous Ops | 4.35 | -0.14 | 0.32 | -0.43 | -0.93 |
| EPS Diluted Total Ops | 2.82 | -0.15 | 0.11 | 0.45 | -0.48 |
| EPS Diluted Continuous Ops | 3.57 | -0.12 | 0.27 | -0.39 | -0.93 |
| EPS Diluted Before Non-Recurring Items | 2.82 | -0.21 | 0.11 | -0.46 | -0.48 |
| EBITDA(a) | $-4,585 | $-2,648 | $-4,839 | $-34,380 | $-20,346 |